Medicare Approves 150+ Tech Companies for Chronic Care

Medicare is rolling out the welcome mat for digital health, and the response is bigger than anyone expected.

The Center for Medicare and Medicaid Innovation just gave provisional approval to over 150 companies and healthcare providers to join ACCESS, an experimental program that pays them to treat chronic conditions using technology. Mental health apps, wearable device makers, and heart failure management startups are all on the list.

The program targets six common conditions: diabetes, high blood pressure, high cholesterol, musculoskeletal pain, anxiety, and depression. Instead of paying for individual tech services, Medicare will pay set rates tied to actual health improvements.

What makes this really exciting? Most of these approved participants have never worked with Medicare patients before. That means millions of seniors could soon get access to tools and treatments that were previously out of reach.

The demand caught officials off guard in the best way possible. Applications flooded in despite modest payment rates and strict restrictions. CMS had to extend the April 1 deadline just to handle all the interest.

The Ripple Effect

This isn't just about apps and gadgets. It's about fundamentally changing how older Americans manage their health.

Right now, many seniors struggle with multiple chronic conditions that require constant monitoring and frequent doctor visits. Digital tools can make that easier, tracking blood sugar levels automatically, sending medication reminders, or connecting patients with mental health support from home.

The program also signals something bigger: Medicare is betting on prevention and outcomes over volume. Companies only get paid when they actually improve patient health, which means they have real skin in the game.

For the participating companies, many of them startups, this is a chance to prove their worth with the nation's largest healthcare program. Success here could reshape how all of healthcare thinks about technology and chronic disease management.

The ACCESS model represents a rare moment when innovation meets access at scale, potentially improving millions of lives while controlling costs.